Acova

Acova Uses, Dosage, Side Effects, Food Interaction and all others data.

Acova is a direct, selective thrombin inhibitor. The American College of Cardiologists (ACC) recommend using bivalirudin or argatroban in patients who have had, or at risk for, heparin induced thrombocytopenia (HIT) and are undergoing percutaneous coronary intervention. Acova is a non-heparin anticoagulant shown to both normalize platelet count in patients with HIT and prevent the formation of thrombi. Parental anticoagulants must be stopped and a baseline activated partial thromboplastin time must be obtained prior to administering argatroban.

Acova is a synthetic direct thrombin inhibitor derived from L-arginine indicated as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. Acova is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Acova does not require the co-factor antithrombin III for antithrombotic activity. Acova exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; protein C; and platelet aggregation. Acova is highly selective for thrombin with an inhibitory constant (Ki) of 0.04 µM. At therapeutic concentrations, Acova has little or no effect on related serine proteases (trypsin, factor Xa, plasmin, and kallikrein).Acova is capable of inhibiting the action of both free and clot-associated thrombin.

Acova
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Acova
Availability	Prescription only
Generic	Argatroban
Argatroban Other Names	Argatroban
Related Drugs	warfarin, Coumadin, heparin, alteplase, Jantoven, streptokinase
Weight	1mg/ml, 100mg/ml
Type	Intravenous solution
Formula	C₂₃H₃₆N₆O₅S
Weight	Average: 508.64 Monoisotopic: 508.246789457
Protein binding	54%
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country	United States
Last Updated:	September 19, 2023 at 7:00 am

Uses

Acova is a synthetic direct thrombin inhibitor used for the prevention and treatment of thrombosis related to heparin use.

Acova is indicated for prevention and treatment of thrombosis caused by heparin-induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention.

Acova is also used to associated treatment for these conditions: Thrombotic events

How Acova works

Acova exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; protein C; and platelet aggregation.

Toxicity

Excessive bleeding

Food Interaction

Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
Exercise caution with grapefruit products. Grapefruit inhibits CYP3A4 metabolism, which may increase the serum concentration of argatroban; however, the evidence is conflicting.
Exercise caution with St. John's Wort.